The Renin-Angiotensin System, Hypertension, and SARS-CoV-2 Infection: a Review

Abstract

Purpose of Review This review focuses on the associations between the renin-angiotensin system, hypertension, and severe acute respiratory syndrome (SARS-COV-2) infection. A brief prelude on the current state of affairs with COVID-19 is given. In addition to an overview of ACE2, Ang II, and Ang (1-7), this review presents a brief statement on hypertension, including the function of enzymes involved in the control of hypertension, cardiovascular disease, diabetes mellitus, and other malignancies. Recent Findings There is currently no data in support of the concerns raised with the use of ACEIs/ARBs. Many researchers have voiced concerns that the use of ACEIs and ARBs may increase tissue ACE2 levels. These researchers therefore recommend that individuals on ACEIs/ARB's medications withhold such antihypertensive drugs, unless advised by their physicians to do so. Summary SARS-CoV-2 uses ACE2 receptors as the port of entry to human hosts. ACE2 and ACE are different enzymes and ACE inhibitors do not inhibit ACE2. Therefore, the use of ARB's or ACEIs should not be discontinued if an individual is infected by SARS-CoV-2. Further studies are required to investigate the effect of ACEIs and ARBs on ACE2 expression and COVID-19. Keywords Renin-angiotensin system . Hypertension . SARS-COV-2 . Angiotensin-converting enzyme inhibitors . Angiotensin II This article is part of the Topical Collection on Blood Pressure Monitoring and Management * Jagidesa Moodley

Elevated Arterial Blood Pressure as a Delayed Complication Following COVID-19—A Narrative Review

“…Arterial hypertension constitutes a significant global health concern with an estimated doubling of affected adults from 1990 to 2019, now encompassing approximately 650 billion individuals [111,112]. The primary goal of treating arterial hypertension is to modify the risk factors, such as lipid disorders, obesity, diabetes, and smoking.…”

Elevated Arterial Blood Pressure as a Delayed Complication Following COVID-19 -Systemic Review

“…ACE-2 is a key player in the RAS,which is important in blood pressure regulation. There are not many articles describing hypertension as a long term consequence of COVID-19 infection [35,.…”

On virus and nanomaterials – Lessons learned from the innate immune system – ACE activation in the invertebrate model Enchytraeus crypticus

“…at the molecular level, covering high-throughput (HTP) gene expression using microarray studies ( Gomes et al, 2018a , Gomes et al, 2019a , Gomes et al, 2017 , Gomes et al, 2018a , Gomes et al, 2018b ). Hence, this species may present a non-animal alternative testing model for studying ACE related expression, keeping in mind that there are various ACE enzymes ( Gathiram et al, 2021 ).…”